Gemtesa 75 MG tablet 90S
Ended Awarded
- Contract number
- SPE2DB25FQJWS
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $36,724
Award facts
- Contract value 100% obligated
- $36,724.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $36.7K on September 19, 2025, for the supply of Gemtesa 75 mg tablets (90 count). This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of September 22, 2025. The award was fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp serves as a prime vendor for federal pharmaceutical procurement, supplying a comprehensive range of medications and medical supplies to support military and veteran healthcare systems. The company competes in the open market for DLA awards and has demonstrated capability across multiple therapeutic domains, including specialty medications, brand-name and generic pharmaceuticals, and medical devices. This particular award for Gemtesa—a medication used in urology—reflects the company's role as a critical distributor within the Defense Health Agency's pharmaceutical supply chain. The SPE2DX contract vehicle enables AmerisourceBergen to provide flexible, responsive pharmaceutical support to federal healthcare customers worldwide, positioning the company as one of several potential contractors under the DLA's planned Pharmaceutical Prime Vendor Global Program Generation V initiative.
Quick answers
Who was awarded contract SPE2DB25FQJWS?
SPE2DB25FQJWS was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 19, 2025.
How much is contract SPE2DB25FQJWS worth?
The government has obligated $36,724 on SPE2DB25FQJWS.
Is contract SPE2DB25FQJWS an order under another contract?
Yes. SPE2DB25FQJWS is a delivery order under SPE2DB25D3005, an indefinite delivery contract.
Was contract SPE2DB25FQJWS competed?
The extent of competition for SPE2DB25FQJWS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award